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Abstract
Over the past 10 years, fluorescent semiconductor quantum dot (QD)-biomolecule conjugates have
emerged as a powerful new sensing platform showing great potential in a wide range of applications
in biosensing, environmental monitoring, and disease diagnosis. This mini-review presents a brief
account of the recent development on QD-nucleic acid (NA), particularly NA aptamer, conjugates
based biosensors using the Förster resonance energy transfer (FRET) readout mechanism. It starts
with a brief introduction to the NA aptamer and QD FRET, followed by example approaches to
compact QD-DNA conjugates, target readout strategies and sensing performance, and concluded
with challenges and outlook for the QD-NA/aptamer bioconjugate sensors.
2NA Aptamer
NA Aptamers are short single-stranded DNA or RNA molecules selected from large,
random DNA or RNA molecule pools (e.g. 1014-1015 molecules) by their ability to bind a
specific target using an in vitro process termed SELEX (systematic Evlution of Ligand by
Explontial Enrichment).[1,2] It is possible to select a NA aptamer against effectively any target
of interest. Once an aptamer sequence is known, it can be produced by chemical synthesis and
followed by stringent chemical purification to avoid batch-to-batch variations. Aptamers have
several advantageous properties over the widely used antibodies as ligand binding agents,[3,4]
including a wider target choice; higher ligand specificity with comparable binding affinity (nM
to pM); production by totally in vitro protocols which combinated with chemical purification,
can eliminate batch-to-batch variation; are more robust against thermal and chemical
denaturation (they can sustain several rounds of denaturation/renaturation process without
loosing ligand binding affinity), and can easily incorporate bespoke functional groups and/or
fluorescent lables site-specifically for easy surface-/bio- conjugation and signal readout. As a
result, NA aptamers have been used in developing sensors for a wide range of different targets:
from DNAs, proteins, environmental pollutants, street drugs, viruses to whole cancer cells.[5,6]
QD-FRET and Challenges
The unique size-dependent, bright and extremely photo-stable fluorescence of QDs make
them well-suited for a range of bio-related applications, imaging, cell tracking/trafficking, and
multiplexed sensing etc.[7-9] Their broad absorption and narrow symmetric emission (with
typical FWHMs of ~25-40 nm) are particularly attractive to FRET based sensing applications
because such spectra characteristics allow for wide selection of excitation wavelengths to
minimize direct excitation of the acceptor, reducing background and improving sensitivity.
[10,11] Besides, different coloured QDs can be excited by a single light sourse, yet producing
specific, narrow and synmetric emissions of different colours, which is very useful for
multiplexing. Further, multiple biomolecules can be arrayed to a single QD to create a
multivalent/multifunctional QD-bioconjugate for enhanced ligand binding affinity and
multiplexed sensing.[8] In general, QDs are excellent donors, but not acceptors in FRET based
applications, because of their broad absorption spectra which make direct excitation of QDs
unavoidable. Furthermore, their relatively long lifetimes (ca. 10-100 ns v.s. < 5 ns for most
organic fluorophores) also make dye to QD FRET inefficient. Therefore almost all most QD-
FRET based sensors reported so far have exclusively used QD as the donor and dye as acceptor,
but not vice versa.[9-11]
3Because FRET efficiency (E, sensitivity) decreases dramatically with the increasing
donor-acceptor distance (r) following the Förster dipole-dipole interaction equation: E = 1/[1 +
(r/R0)6], where R0 is the Förster radius of a single donor-acceptor pair under which E = 50%,
this has posed a considerable challenge to achieve high sensitivity for QD-FRET sensors due to
the signficant sizes of the QDs.[10] HRs for water-soluble QDs alone (core + surface coating,
ca. ~5-25 nm depending on solubilisation strategies) can often be comparable or greater than
the R0 (ca. 4-7 nm) of most QD-dye FRET pairs prior to bioconjugation.[10,11] As a result,
most QD-FRET sensors have relied on increasing the number of acceptor per QD (n) to improve
the E, because E = 1/[1 + r6/(nR06)] in a single-donor-multiple acceptors FRET system.[10]
However, such systems are inefficient and often unsuitable for low n situations (e.g. 1) because
of the small FRET change obtainable from a single target binding in such QD sensors.[12,13]
Therefore considerable efforts have been focused on developing compact water-soluble QDs
and effective bioconjugation chemistries to reduce r values.[14-20] Desipte several strategies
have been reported to make water-soluble QDs, so far none can produce QDs that are compact
(HR < 5 nm), highly stable in biological buffers and resisting non-specific adsorption, key
requirements for robust, sensitive, and specific clinical bioassays. In general, water-soluble QDs
prepared via ligand exchange are compact, but often exhibit limited stability in biological
buffers and cannot prevent non-specific adsorption; whereas QDs solublised via capping with
amphiliplic polymer[21] or PEGylated lipipids [22] are stable, resisting non-specific adsportion,
but have large HRs (> 10 nm), limiting the sensitivity. Table 1 summarises a few frequently
used QD-bioconjugation chemistries for making compact QD-DNA conjugates and their Es at
low n situations.
Table 1. FRET efficiencies (E) of some compact QD-DNA conjugates prepared via different bioconjugation
chemistries at n = 1 except for those specifically indicated in the bracket. Abbreviations for “xxx-QDyyy” are:
xxx = QD surface capping ligand, yyy = QD emission wavelength (nm).
QD-dye FRET system DNA conjugation chemistry E Readout RefMPA-QD550-Alexa 594 Thiolate self-assembly (ZnS shell) 81% SMF [14]MPA-QD550-Alexa 594 Thiolate self-assembly (ZnS shell) ~50% FS [14]DHLA-QD550-Atto 647N Thiolate self-assembly (ZnS shell) 34% FS [11]DHLA-QD510-TAMAR His6-tag-metal affinity (ZnS shell) 60% (n=2) FS [16]DHLA-QD590-Cy5 His6-tag-metal affinity (ZnS shell) ~21% FS [16]MAA-QD520-Cy3 Covalent coupling (surface ligand) 52% Life time [23]MAA-QD600-Alexa 647 Covalent coupling (surface ligand) 6.7% Life time [23]EG3-QD550-Alexa 594 Covalent binding (surface ligand) 28% FS [17]STV-QD585-Cy5 STV-biotin interaction ~5.5% SM [12]
4Approaches to Compact QD-DNA Conjugates
The most straightforward approach to compact QD-DNA conjugates is to directly bind the
DNAs to the QD surface (via Zn2+ in CdSe/ZnS core/shell QDs). Here two different approaches
have been reported: Mattoussi and co-workers [16] used the His6-tagged DNA and DHLA-QD self-
assembly to produce compact QD-DNA conjugates and efficient FRET (E = 60% for n = 2). They
have also used such QD-DNA conjugate for label-free DNA detection by incorporating a DNA
molecular beacon. We found that thiolated DNAs could self-assemble onto MPA- or DHLA- QDs,
producing compact QD-DNA conjugates and high E at low n situations.[11,14] Interestingly, the
MPA (a monodentate ligand)-QD produced stronger E than the DHLA (a chelative ligand)-QD
(80% v.s. 34% for n = 1), suggesting the QD surface capping ligands strongly affect the DNA
conformation in the QD-DNA assemblies. For the MPA-QD, the DNA strands may wrap around
the QD, yielding small r and strong E; while for the DHLA-QD, the DNA strands are extended,
leading to big r and weak E. This was supported by the observation that self-assembled MPA-QD-
ssDNA could not hybridise to its complementary DNA, whereas DHLA-QD-ssDNA could.[11,14]
Similar structural differences were also observed in a recent QD-FP (His6-tagged) self-assembly
study, where r value for the MPA-QD was found to be ~2.5 nm shorter than that of the DHLA-QD
despite using identical His6-tag-Zn2+ coordination in the bioconjugation.[23]
Another approach to compact QD-DNA conjugate is to covalently couple the DNAs to the
QD surface functional groups. The binding strength and chain length of the ligands are critical for
structural compactness (sensitivity) and specificity of the resulting QD-DNA conjugate sensor. For
example, Algar and Krull [24] prepared compact QD-DNA conjugates with efficient FRET (E up to
52% at n = 1) by coupling amine-modified DNA to a MAA-capped QD. However, its specificity
was rather low, with a FRET ratio of only ~2 between complementary and non-complementary
DNA target, suggesting MAA cannot resist non-specific adsorption.[23] We found that EG3 capped
QD could effectively resist non-specific adsorption while maintaining a relatively compact QD-
DNA structure (E = 28% for n = 1), the resulting QD-DNA conjugate is suitable for quantitation of
low nM specific complementary DNA.[17] More recently, we have developed a novel CDL that can
provide stable, compact and entangled capping to the QD, allowing highly specific detection of pM
complementary DNA target.[11,18]
The third common approach to QD-DNA conjugate is via biospecific interactions, e.g.
biotin-streptavidin interaction.[12,25,26,28-30] This process is very simple, by simply mixing
commercially available STV-QD with biotinylated DNA usually lead to reliable, efficient QD-DNA
conjugation. The drawback here is the large size of the STV-QD (HR >12 nm), leading to
5inefficient FRET at low n situations (e.g. E ~ 5% at n = 1).[12] These systems are generally suitable
only for high n situations [26,28-30] or those using very efficient quenchers, e.g. GNPs.[25]
QD-DNA/Aptamer FRET sensors
Figure 1 summarises some common readout approaches in QD-NA/aptamer conjugate
based biosensors. Schemes (A-E) are QD-DNA conjugate sensors for DNA detection and schemes
(F-J) are QD-aptamer sensors for non-DNA target detection. Their specific sensing performance
(e.g. detection limit and dynamic range) are summarised in Table 2. A unique advantage for FRET
based biosensor over other techniques is its short range interaction: it only detects species within the
FRET range (e.g. < 10 nm), any unbound species are undetected because they cannot participate the
FRET process, allowing assays to be carried out in a convenient, separation-free format even with
excess of unbound species.[10,11]
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Figure 1. Schematics of commonly used sensing mechanisms in the QD-NA/aptamer conjugates basedfluorimetric biosensors. Red dots: fluorescent or intercalating dyes; black dot: organic or GNPquencher; blue object: luciferace.
Schemes (A-C) are “target on” assays, where hybridisation of target DNA to the QD-DNA
conjugate produces the readout FRET signal: (A) directly uses the hybridised DNA targets (dye-
labelled) for FRET readout;[11,18,24] (B) is a label-free alternative to (A), which uses intercalated
dye molecules within the hybridised dsDNA as acceptor for FRET readout;[17] and (C) uses the
6target DNA to cross-link the QD-capture and dye-labelled reporter DNAs, forming a capture/target
/reporter sandwich for FRET readout.[13] (D) uses the FRET change resulting from conformational
change of a QD-conjugated molecular beacon upon target DNA hybridisation for signal readout.
[16] (E) is a displacement assay, where target DNA binding displaces the luciferase-DNA from the
QD-DNA conjugate, reducing luciferase to QD BRET signal as target readout.[27]
Schemes (F-J) show common sensing mechanisms used in QD-aptamer biosensors for non-
DNA targets. (F-H) are displacement assays: where target-aptamer binding displaces the signal
DNA strands from the QD-aptamer conjugate (e.g. GNP [25] or quencher-linked [26,28] DNAs in
(F); dye-labelled DNAs in (G);[11,29] and unlabelled DNAs with intercalated dyes in (H)),[30]
leading to FRET changes as readout signal. (I) uses the QD fluorescence quenching by QD to
bound target electron transfer as signal readout.[31,32] (J) is target induced assembly assay,[33]
where the aptamer sequence is split into two halves, each connected to half of a hermin binding
domain. The presence of target assembles the two-half aptamer units, leading to the formation of a
complete hermin binding site acting as chemical luminescence centre and CRET signal for target
readout.[34,35]
Table 2. Summary of the sensing performance of some QD-NA/aptamer biosensorsSensing Target Detection Detection Detectable RefMechanism Method limit rangeQD-BRET DNA (22 mer) FS 20 nM 20-130 nM [27]QD-FRET DNA (30 mer) SMF 48 fM 0.048-48 pM [13]QD-FRET DNA (30 mer) FS 1 nM 1-200 nM [17]QD-FRET DNA (30 mer) FS 0.5 nM 0-12 nM [18]QD-FRET DNA (24 mer) FS 12 nM 2-50 nM [23]QD-FRET DNA (30 mer) FS 35 pM 0-2 nM [11]QD-FRET Thrombin FS 10 nM 10-1000 nM [11]QD-MB FRET Thrombin FS 1 nM 1-500 nM [30]ET quenching Thrombin FS 10 nM 10-210 nM [32]ET quenching Cocaine FS 1 M 1-1000M [32]QD-FRET Mucin-1 FS 250 nM 0.25-2 M [33]QD-FRET Cocaine SMF 0.5 M 1-8 M [29]QD-GNP quenching Cocaine FS 120 M 50-1000 M [25]QD-GNP quenching Adenosine FS 50 M 50-2000 M [25]QD-ET quenching Hg2+ FS 10 nM 0.01-100 M [31]QD-ET quenching Ag+ FS 1 M 1-30 M [31]QD-CRET ATP FS 0.1 M 0.1-100M [34]
A number of different targets, DNAs, proteins, metal ions and small-molecules, have been
detected by the QD-NA/aptamer fluorimetric sensors (Table 2). The sensitivity and dynamic range
7vary significantly from target to target and assay types. In general, the detection limits achieved for
macromolecular targets are significantly lower, by ~ 3 orders of magnitudes, than those for small-
molecule targets (nM v.s. M). This appears to be a positive reflection of the differences in binding
affinities (e.g. nM v.s. M) and energies of these two types of aptamer-target binding interactions.
[4-6] Another notable observation is the significantly higher sensitivity achieved for DNA detection
by using the SMF readout over conventional FS based assays (48 fM v.s. nM), which can be
attributed to the extremely high detection capability of the SMF approach, down to single-molecule
(QD) level.[13] For most QD-NA/aptamer biosensors using conventional FS readout, their
sensitivities are comparable or better than most other more established electrochemical,[36] surface
plasmon resonance [37] or quartz crystal microbalance [38] based biosensors using direct detection
without further target amplification (which typically have nM sensitivity for DNA/protein, and M
for small-molecule/metal-ion targets). An advantage for the QD-NA/aptamer FRET biosensor is its
ratiometric signal, which is effectively insensitive to instrument noise and/or signal fluctuations,
allowing for accurate, reliable detection even in the presence of excess of unbound species.[10,11]
It should be noted that most of the QD-FRET biosensors reported so far have only demonstrated the
“proof-of-principle” application in clean buffers. Few have showed robust operation in complex
media, such as serum or other biological fluids, which are more relevant to real clinical samples,
most likely due to limited stability and specificity of current QD-aptamer sensors.
Summary and Outlook
Significant progress in QD-NA/aptamer fluorimetric biosensors has been made over the past
10 years, where several assay formats capable of detection of different targets have been developed.
Thanks for their unique short-range interaction readout mechanism and ratiometric signal,[10,11]
the QD-NA/aptamer FRET based sensors can provide reliable, multiplexed detection of different
targets in a convenient, separation-free manner. Since NA aptamers can be selected against virtually
8any targets of choice,[1-4] the QD-NA/aptamer sensor thus appears to be a highly promising new
sensing platform with broad biotechnological, environmental, and clinical applications.[8-11] This
is evident from the exponential growth in both the numbers of publications and citations over the
past 10 years (see Supporting Information, Figure 1). Despite these, most QD-NA/aptamer sensors
reported so far have only demonstrated “proof-of-principle” applications in clean buffers. Few have
attempted in biological fluids or real clinical samples, limited mainly by the sensitivity, specificity
and robustness of current QD-NA/aptamer sensors. Specifically, their sensitivity and specificity,
especially assay robustness, have yet to match those of current “gold-standard” clinical assays such
as ELISA (typically with pM sensitivity). Future researches are likely to focus on improving the
sensitivity, specificity and robustness of the QD-aptamer biosensors via optimisation of water-
solubilisation [19] and QD-DNA conjugation [20] strategies, and extend their applications in real
clinical samples.
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